Мозг: от хорошего к превосходному

Список литературных источников

Johnson, D. L., et al. «Cerebral Blood Flow and Personality: A Positron Emission Tomography Study», American Journal of Psychiatry 156, no. 2 (February 1999: 252–57.

Keightley, M. L., et al. «Personality Influences Limbic-Cortical Interactions During Sad Mood Induction», Neuroimage 20, no. 4 (December 2003): 2031–39.

Kumari, V., et al. «Personality Predicts Brain Responses to Cognitive Demands», Journal of Neuroscience 24, no. 47 (November 24, 2004): 10 636-41.

Sugiura, М., et al. «Correlation Between Human Personality and Neural Activity in Cerebral Cortex», Neuroimage 11, no. 5, pt. 1 (May 2000): 541–46.

Turner, R. M., et al. «Brain Function and Personality in Normal Males: A SPECT Study Using Statistical Parametric Mapping», Neuroimage 19, no. 3 (July 2003: 1145–62.

Youn, Т., et al. «Relationship Between Personality Trait and Regional Cerebral Glucose Metabolism Assessed with Positron Emission Tomography», Biological Psychology 60, no. 2–3 (September 2002): 109–20.

Alptekin, K., et al. «Tc-99m HMPAO Brain Perfusion SPECT in Drug-Free Obsessive-Compulsive Patients Without Depression», Psychiatry Research 107, no. 1 (July 1, 2001): 51–56.

Catafau, A. М., et al. «Regional Cerebral Blood Flow Pattern in Normal Young and ged Volunteers: A 99mTc-HMPAO SPET study», European Journal of Nuclear Medicine 23, no. 10 (October 1996): 1329–37.

George, M. S., et al. «Elevated Frontal Cerebral Blood Flow in Gilles de la Tourette Syndrome: A 99Tcm-HMPAO SPECT Study», Psychiatry Research 45, no. 1 (November 1992): 143–51.

Goto, R., et al. «A Comparison of Tc-99m HMPAO Brain SPECT Images of Young and Aged Normal Individuals», Annals of Nuclear Medicine 12, no. 6 (December 1998): 333–39.

Lacerda, A. L., et al. «Elevated Thalamic and Prefrontal Regional Cerebral Blood Flow in Obsessive-Compulsive Disorder: A SPECT Study», Psychiatry Research 123, no. 2 (June 30, 2003): 125–34.

Machlin, S. R., et al. «Elevated Medial-Frontal Cerebral Blood Flow in Obsessive-Compulsive Patients: A SPECT Study», American Journal of Psychiatry 148, no, 9 (September 1991): 1240–42.

Mena, Francisco J., et al. «Children Normal HMPAO Brain SPECT», Alasbimn Journal 1, no. 1 (September 1998); http://www.alasbimnjournal.cl/revistas/ 1/children.htm.

Saxena, S., R. G. Bota, and A. L. Brody, «Brain-Behavior Relationships in Obsessive-Compulsive Disorder», Seminars in Clinical Neuropsychiatry 6, no. 2 (April 2001): 82–101.

Neuroscience for Kids http://faculty.washington.edu/chudler/neurok.html

The Franklin Institute Online http://sln.fi.edu/qa97/spotlight5/spotlight5.html

Abdel-Dayem, H. M., et al. «SPECT Brain Perfusion Abnormalities in Mild or Moderate Traumatic Brain Injury», Clinical Nuclear Medicine 23, no. 5 (May): 309–17 0.

Abu-Judeh, H. H., et al. «SPECT Brain Perfusion Imaging in Mild Traumatic Brain Injury Without Loss of Consciousness and Normal Computed Tomography», Nuclear Medicine Communications 20, no. 6 (June 1999): 305–10.

Barnes, В. C., et al. «Concussion History in Elite Male and Female Soccer Players», American journal of Sports Medicine 26, no. 3 (May-June 1998): 433–38.

Bergsneider, М., et al. «Metabolic Recovery Following Human Traumatic Brain Injury Based on FDG-PET: Time Course and Relationship to Neurological Disability», Journal of Head Trauma Rehabilitation 16, no. 2 (April 2001): 135–48.

Babbs, C. F., «Biomechanics of Heading a Soccer Ball: Implications for Player Safety», Scientific World Journal 1 (August 8, 2001): 281–322.

Boll, T. J., and J. Barth, «Mild Head Injury», Psychiatric Development 1, no. 3 (Autumn 1983): 263–75.

Furtak, J., K. Chmielowski, and J. K. Podgorski, «Epidemiology, Diagnosis and Prognosis in the Clinical Syndrome of Brain Concussion», Neurologia i neurochirurgia polska 30, no. 4 (July-August 1996): 625–30.

Goshen, E, et al. «The Role of 99Tcm-HMPAO Brain SPECT in Paediatric Traumatic Brain Injury», Nuclear Medicine Communications 17, no. 5 (May 1996): 418–22.

Jacobs, A., et al. «One-Year Follow-up of Technetium-99m-HMPAO SPECT in Mild Head Injury», Journal of Nuclear Medicine 37, no. 10 (October 1996): 1605–09.

Kemp, P. М., et al. «Cerebral Perfusion and Psychometric Testing in Military Amateur Boxers and Controls», Journal of Neurology, Neurosurgery and Psychiatry 59, no. 4 (October 1995): 368–74.

Kirkendall, D. Т., S. E. Jordan, and W. E. Garrett, «Heading and Head Injuries in Soccer», Sports Medicine 31, no. 5 (2001): 369–86.

Lovell, M. R., et al. «Recovery from Mild Concussion in High School Athletes», Journal of Neurosurgery 98, no. 2 (February 2003): 296–301.

Massagli, T. L., et al. «Psychiatric Illness After Mild Traumatic Brain Injury in Children», Archive of Physical Medicine and Rehabilitation 85, no. 9 (September 2004): 1428–34.

Matser, E. J., et al. «Neuropsychological Impairment in Amateur Soccer Players», Journal of the American Medical Association 282, no. 10 (September 8, 1999): 971–73.

Tysvaer, А. Т., О. V. Storli, N. I. Bachen, «Soccer Injuries to the Brain. A Neurologic and Electroencephalographic Study of Former Players», Acta Neurologica Scandinavica 80, no. 2 (August 1989): 151–56.

Amen, D. G., «Change Your Brain, Change Your Life» (New York: Three Rivers Press, 2000).

Bogg, Т., and B. W. Roberts, «Conscientiousness and Health-Related Behaviors: A Meta-Analysis of the Leading Behavioral Contributors to Mortality», Psychological Bulletin 130, no. 6 (November 2004): 887–919.

Kolb, B., and I. Wishaw, «Fundamentals of Human Neuropsychology» (New York: W.H. Freeman and Co., 2003).

Miller, B., and J. Cummings, «The Human Frontal Lobes» (New York: Guilford Press, 1998).

Amen, D. G., «Healing ADD» (New York: Putnam, 2001).

Amen, D. G., and L. C. Routh, «Healing Anxiety and Depression» (New York: Putnam, 2003).

Diagnostic and Statistical Manual of Mental Disorders IV-TR (New York: American Psychiatric Association, 2000).

Amen, D. G., J. C. Wu, and B. L. Carmichael, «The Clinical Use of Brain SPECT Imaging in Neuropsychiatry», Alasbimn Journal 5, no. 19 (January 2003); http://www2.alas-bimnjournal.d/alasbimn/CDA/sec_b/0, 1206, SCID%253D3212.00.html.

Amen, D. G., «Why Don’t Psychiatrists Look at the Brain: The Case for the Greater Use of SPECT Imaging in Neuropsychiatry», Neuropsychiatry Reviews 2, no. 1 (February 2001): 19–21.

«Brain SPECT Imaging in Psychiatry», Primary Psychiatry 5, no. 8 (August 1998): 83–90.

«Brain SPECT Imaging and ADD», in Understanding, Diagnosing, and Treating AD/HD in Children and Adolescents: An Integrative Approach, edited by J. A. Incorvaia, et al. (Northvale, N.J.: Jason Aronson, 1999): 183–96.

«New Directions in the Theory, Diagnosis, and Treatment of Mental Disorders: The Use of SPECT Imaging in Everyday Clinical Practice», in The Neuropsychology of Mental Disorders, edited by L.F. Koziol and C.E. Stout (Springfield, 111.: Charles C. Thomas, 1994): 286–311.

Wu, J. C., D. G. Amen, and S. Bracha, «Functional Neuroimaging in Clinical Practice», in The Comprehensive Textbook of Psychiatry, edited by H.I. Kaplan and B.J. Sadock (Philadelphia: Lippincott Williams and Wilkins, 2000).

Amen, D. G., «Change Your Brain, Change Your Life» (New York: Three Rivers Press, 2000).

«Healing the Hardware of the Soul» (New York: Free Press, 2002).

«Three Years on Clomipramine: Before and After Brain SPECT Study», Annals of Clinical Psychiatry 9, no. 2 (1997): 113–16.

Carey, P. D., et al. «Single Photon Emission Computed Tomography (SPECT) of Anxiety Disorders Before and After Treatment with Citalopram», BMC Psychiatry 4, no. 1 (October 2004): 30.

Catafau, A. М., et al. «SPECT Mapping of Cerebral Activity Changes Induced by Repetitive Transcranial Magnetic Stimulation in Depressed Patients. A Pilot Study», Psychiatry Research 106, no. 3 (May 30, 2001): 151–60.

Dormehl, I. C., et al. «SPECT Monitoring of Improved Cerebral Blood Flow During Long-term Treatment of Elderly Patients with Nootropic Drugs», Clinical Nuclear Medicine 24, no. 1 (January 1999): 29–34.

Furmark, T., et al. «Common Changes in Cerebral Blood Flow in Patients with Social Phobia Treated with Citalopram or Cognitive-Behavioral Therapy», Archives of General Psychiatry 59, no. 5 (May 2002): 425–33.

Golden, Z. L., et al. «Improvement in Cerebral Metabolism in Chronic Brain Injury After Hyperbaric Oxygen Therapy», International Journal of Neuroscience 112, no. 2 (February 2002): 119–31.

Holthoff, V. A., et al. «Changes in Regional Cerebral Perfusion in Depression. SPECT Monitoring of Response to Treatment», Nervenarzt 70, no. 7 (July 1998): 620–26.

Laatsch, L., et al. «Impact of Cognitive Rehabilitation Therapy on Neuropsychological Impairments as Measured by Brain Perfusion SPECT: A Longitudinal Study», Brain Injury 11, no. 12 (December 1997): 851–63.

Lansing, K., D. G. Amen, and C. Hanks, «High Resolution Brain SPECT Imaging and EMDR in Police Officers with PTSD», Journal of Neuropsychiatry (2005).

Levin, P., S. Lazrove, and B. van der Kolk, «What Psychological Testing and Neuroimaging Tell Us About the Treatment of Posttraumatic Stress Disorder by Eye Movement Desensitization and Reprocessing», Journal of Anxiety Disorders 13, no. 1–2 (January-April 1999): 159–72.

Martin, S. D., et al. «Brain Blood Flow Changes in Depressed Patients Treated with Interpersonal Psychotherapy or Venlafaxine Hydrochloride: Preliminary Findings», Archives of General Psychiatry 58, no. 7 (July 2001): 641–48.

Paquette, V., et al. «Change the Mind and You Change the Brain: Effects of Cognitive-Behavioral Therapy on the Neural Correlates of Spider Phobia», Neuroimage 18, no. 2 (February 2003): 401–09.

Santos, R. F., et al. «Cognitive Performance, SPECT, and Blood Viscosity in Elderly Non-demented People Using Ginkgo Biloba», Pharmacopsychiatry 36, no. 4 (July 2003): 127–33.

Shi, X. Y., «Cerebral Perfusion SPECT Imaging for Assessment of the Effect of Hyperbaric Oxygen Therapy on Patients with Postbrain Injury Neural Status», Chinese Journal of Traumatology 6, no. 6 (December 2003): 346–49.

Vasile, R. G., et al. «Changes in Regional Cerebral Blood Flow Following Light Treatment for Seasonal Affective Disorder: Responders Versus Nonresponders», Biological Psychiatry 42, no. 11 (December 1, 1997): 1000–05.

«Mental Health: A Report of the Surgeon General», http://www.surgeongeneral.gov/ library/ mentalhealth/home.html

Ortberg, J., «Everybody's Normal Till You Get to Know Them» (Grand Rapids, Mich.: Zondervan, 2003).

Chang, L., et al. «Effect of Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on Cerebral Blood Flow: A Co-registered SPECT and MRI Study», Psychiatry Research 98, no. 1 (February 28, 2000): 15–28.

Dupont, R. M., et al. «Single Photon Emission Computed Tomography with Iodoam-phetamine-123 and Neuropsychological Studies in Long-term Abstinent Alcoholics», Psychiatry Research 67, no. 2 (July 1996): 99–111.

Erbas, B., et al. «Regional Cerebral Blood Flow Changes in Chronic Alcoholism Using Tc-99m HMPAO SPECT. Comparison with CT Parameters», Clinical Nuclear Medicine 17, no. 2 (February 1992): 123–27.

Ernst, T., et al. «Cerebral Perfusion Abnormalities in Abstinent Cocaine Abusers: A Perfusion MRI and SPECT Study», Psychiatry Research 99, no. 2 (August 28, 63–74).

Gerra, G., et al. «Regional Cerebral Blood Flow and Comorbid Diagnosis in Abstinent Opioid Addicts», Psychiatry Research 83, no. 2 (August 26, 1998): 117–26.

Harris, G. J., et al. «Hypoperfusion of the Cerebellum and Aging Effects on Cerebral Cortex Blood Flow in Abstinent Alcoholics: A SPECT Study», Alcoholism-Clinical and Experimental Research 23, no. 7 (July 1999): 1219–27.

Holman, B. L., et al. «Brain Perfusion is Abnormal in Cocaine-Dependent Polydrug Users: A Study Using Technetium-99m-HMPAO and SPECT», Journal of Nuclear Medicine 32, no. 6 (June 1991): 1206–10.

Iyo, М., et al. «Abnormal Cerebral Perfusion in Chronic Methamphetamine Abusers: A Study Using 99MTc-HMPAO and SPECT», Progress in Neuro-psychopharmacol and Biological Psychiatry 21, no. 5 (July 1997): 789–96.

Kao, C. H., S. J. Wang, and S. H. Yeh, «Presentation of Regional Cerebral Blood Flow in Amphetamine Abusers by 99Tcm-HMPAO Brain SPECT», Nuclear Medicine Communications 15, no. 2 (February 1994): 94–98.

Kucuk, N. O., et al. «Brain SPECT Findings in Long-term Inhalant Abuse», Nuclear Medicine Communications 21, no. 8 (August 2000): 769–73.

Lotfi, J., and J. S. Meyer, «Cerebral Hemodynamic and Metabolic Effects of Chronic Alcoholism», Cerebrovascular and Brain Metabolism Review 1, no. 1 (Spring 1989): 2–25.

Mathew, R. J., et al. «Marijuana Intoxication and Brain Activation in Marijuana Smokers», Life Sciences 60, no. 23 (1997): 2075–89.

Miller, B. L., et al. «Neuropsychiatric Effects of Cocaine: SPECT Measurements», Journal of Addictive Diseases 11, no. 4 (1992): 47–58.

Okada, S., et al. «Regional Cerebral Blood Flow Abnormalities in Chronic Solvent Abusers», Psychiatry and Clinical Neurosciences 53, no. 3 (June 1999): 351–56.

Volkow, N. D., et al. «Decreased Brain Metabolism in Neurologically Intact Healthy Alcoholics», American Journal of Psychiatry 149, no. 8 (August 1992): 1016–22.

Baker, В., «Head Injury Confers Alzheimer’s Risk Regardless of Apo E-4 Status», Clinical Psychiatry News 28, no. 1 (2000).

De Deyn, P. P., et al. «From Neuronal and Vascular Impairment to Dementia», Pharmacopsychiatry 32 (Supp.) (1999): 17–24.

Graham, D. I., et al. «Apolipoprotein E and the Response of the Brain to Injury», Acta Neurochirurgica 73 (Suppl.) (1999): 89–92.

Johnstone, В., М. K. Childers, and J. Hoerner, «The Effects of Normal Ageing on Neuropsychological Functioning Following Traumatic Brain Injury», Brain Injury 12, no. 7 (1998): 569–76.

Jordan, B. D., et al. «Apolipoprotein E4 Associated with Chronic Traumatic Brain Injury in Boxing», Journal of the American Medical Association 278, no. 2: 136–40.

Kerr, М. E., and M. Kraus, «Genetics and the Central Nervous System: Apolipoprotein E and Brain Injury», AACN Clinical Issues 9, no. 4 (1998): 524–30.

Mayeux, R., et al. «Synergistic Effects of Traumatic Head Injury and Apolipoprotein E-4 in Patients with Alzheimer’s Disease», Neurology 48 (1995): 555–57.

Nemetz, P. N., et al. «Traumatic Brain Injury and Time to Onset of Alzheimer’s Disease: A Population-Based Study», American Journal of Epidemiology 149, no. 1 (1999): 32–40.

Rasmusson, D. X., et al. «Head Injury as a Risk Factor in Alzheimer’s Disease», Brain Injury 9, no. 3 (1995): 213–19.

Salib, E., and V. Hillier, «Head Injury and the Risk of Alzheimer’s Disease: A Case Control Study», International Journal of Geriatric Psychiatry 12 (1999): 363–68.

Shankle, W. R., and D. G. Amen, «Preventing Alzheimer’s» (New York: Putnam, 2004).

Yamada, М., et al. «Prevalence and Risks of Dementia in the Japanese Population: RERF’s Adult Health Study Hiroshima Subjects», Journal of the American Geriatrics Society 47 (1999): 189–95.

Field, A. S., et al. «Dietary Caffeine Consumption and Withdrawal: Confounding Variables in Quantitative Cerebral Perfusion Studies?» Radiology 227, no. 1:129–35.

Hoecker, C., et al. «Caffeine Impairs Cerebral and Intestinal Blood Flow Velocity in Preterm Infants», Pediatrics 109, no. 5 (May 2002): 784–87.

Laurienti, P. J., et al. «Dietary Caffeine Consumption Modulates fMRI Measures», Neuroimage 17, no. 2 (October 2002): 751–57.

Lunt, M. J., et al. «Comparison of Caffeine-Induced Changes in Cerebral Blood Flow and Middle Cerebral Artery Blood Velocity Shows That Caffeine Reduces Middle Cerebral Artery Diameter», Physiological Measurement 25, no. 2 (April 2004): 467–74.

Mathew, R. J., and W. Н. Wilson, «Caffeine-Induced Changes in Cerebral Circulation», Stroke 16, no. 5 (September-October 1985): 814–17.

Mathew, R. J., D. L. Barr, and M. L. Weinman, «Caffeine and Cerebral Blood Flow», British Journal of Psychiatry 143 (December 1983): 604–08.

Ragab, S., et al. «Caffeine Reduces Cerebral Blood Flow in Patients Recovering from an Ischaemic Stroke», Age and Ageing 33, no. 3 (May 2004): 299–303.

Domino, E. E, et al. «Nicotine Effects on Regional Cerebral Blood Flow in Awake, Resting Tobacco Smokers», Synapse 38, no. 3 (Dec. 1, 2000): 313–21.

Ghatan, P. H., et al. «Cerebral Effects of Nicotine During Cognition in Smokers and Non-smokers», Psychopharmacology 136, no. 2 (March 1998): 179–89.

Kubota, K., et al, «Effects of Smoking on Regional Cerebral Blood Flow in Neurologically Normal Subjects», Stroke 14, no. 5 (September-October 1983): 720–24.

Pergadia, M., et al. «Double-Blind Trial of the Effects of Tryptophan Depletion on Depression and Cerebral Blood Flow in Smokers», Addictive Behaviors 29, no. 4 (June 2004): 668–71.

Rose, J. E., et al. «PET Studies of the Influences of Nicotine on Neural Systems in Cigarette Smokers», American journal of Psychiatry 160, no. 2 (February 2003): 323–33.

Yamashita, K., et al. «Effect of Smoking on Regional Cerebral Blood Flow in the Normal Aged Volunteers», Gerontology 34, no. 4 (1988): 199–204.

Bliwise, D. L., «Sleep Apnea, APOE4 and Alzheimer’s Disease 20 Years and Counting?» Journal of Psychosomatic Research 53, no. 1 (July 2002): 539–46.

Drummond, S. R, et al. «Sleep Deprivation-Induced Reduction in Cortical Functional Response to Serial Subtraction», Neuroreport 10, no. 18 (December 16, 3745–48.

Miller, G., «Society for Neuroscience Meeting. Brain Cells May Pay the Price for a Bad Nights Sleep», Science 306, no. 5699 (Nov. 12, 2004): 1126.

Spiegel, K., «Leptin Levels Are Dependent on Sleep Duration: Relationships with Sympathovagal Balance, Carbohydrate Regulation, Cortisol, and Thyrotropin», Journal of Clinical Endocrinology and Metabolism 89, no. 11 (November 2004): 5762–71.

Spiegel, K., et al. «Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite», Annals of Internal Medicine 141, no. 11 (December 7, 2004): 846–50.

Tanaka, H., and S. Shirakawa, «Sleep Health, Lifestyle and Mental Health in the Japanese Elderly: Ensuring Sleep to Promote a Healthy Brain and Mind», Journal of Psychosomatic Research 56, no. 5 (May 2004): 465–77.

Duval, F., et al. «Increased Adrenocorticotropin Suppression Following Dexamethasone Administration in Sexually Abused Adolescents with Post-traumatic Stress Disorder», Psychoneuroendocrinology 29, no. 10 (November 2004): 1281–89.

Lansing, К., et al. «High Resolution Brain SPECT Imaging and EMDR with Police Officers Involved in Shootings», Journal of Neuropsychiatry and Clinical Neuroscience (in press).

Levin, P., S. Lazrove, and B. van der Kolk, «What Psychological Testing and Neuroimaging Tell Us About the Treatment of Posttraumatic Stress Disorder by Eye Movement Desensitization and Reprocessing», Journal of Anxiety Disorders 13, no. 1–2 (January-April 1999): 159–72.

Sala, М., et al. «Stress and Hippocampal Abnormalities in Psychiatric Disorders», European Neuropsychopharmacology 14, no. 5 (October 2004): 393–405.

Stein, М. B., et al. «Enhanced Dexamethasone Suppression of Plasma Cortisol in Adult Women Traumatized by Childhood Sexual Abuse», Biological Psychiatry 42, no. 8 (October 15, 1997): 680–86.

Yehuda, R., et al. «Enhanced Suppression of Cortisol Following Dexamethasone Administration in Post-traumatic Stress Disorder», American Journal of Psychiatry 150, no. 1 (January 1993): 83–86.

Yehuda, R., «Biology of Post-traumatic Stress Disorder», Journal of Clinical Psychiatry 62, supp. 17 (2001): 41–46.

Barberger-Gateau, P., «Fish, Meat, and Risk of Dementia: Cohort Study», British Medical journal 325, no. 7370 (October 26, 2002): 932–33.

Conquer, J. A., et al. «Fatty Acid Analysis of Blood Plasma of Patients with Alzheimer’s Disease, Other Types of Dementia, and Cognitive Impairment», Lipids 35, no. 12 (December 2000): 1305–12.

Ingram, D. K., et al. «Development of Calorie Restriction Mimetics as a Prolongevity Strategy», Annals of the New York Academy of Science 1019 (June 2004): 412–23.

Kim, Y. K., and A. M. Myint, «Clinical Application of Low Serum Cholesterol as an Indicator for Suicide Risk in Major Depression», Journal of Affective Disorders 81, no. 2 (August 2004): 161–66.

Kim, Y. K., et al. «Low Serum Cholesterol Is Correlated to Suicidality in a Korean Sample», Acta Psychiatrica Scandinavica 105, no. 2 (February 2002): 141–48.

Larrieu, S., et al. «Nutritional Factors and Risk of Incident Dementia in the PAQUID Longitudinal Cohort», Journal of Nutrition, Health, and Aging 8, no. 3 (2004): 150–54.

Liu, J., et al. «Malnutrition at Age 3 Years and Externalizing Behavior Problems at Ages 8, 11, and 17 Years», American Journal of Psychiatry 161, no. 11 (Nov. 2004): 2005–13.

Mattson, M. P., W. Duan, and Z. Guo, «Meal Size and Frequency Affect Neuronal Plasticity and Vulnerability to Disease: Cellular and Molecular Mechanisms», Journal of Neurochemistry 84, no. 3 (February 2003): 417–31.

Mdlwain, H., and H. S. Bachelard, «Biochemistry and the Central Nervous System» (Edinburgh: Churchill Livingstone, 1985).

Molteni, R., et al. «A High-Fat, Refined Sugar Diet Reduces Hippocampal Brain-Derived Neurotrophic Factor, Neuronal Plasticity, and Learning», Neuroscience 112, no. 4 (2002): 803–14.

Roth, G. S., D. К. Ingram, and M. A. Lane, «Caloric Restriction in Primates and Relevance to Humans», Annals of the New York Academy of Sciences 928 (April: 305–15.

Wu, A., et al. «A Saturated-Fat Diet Aggravates the Outcome of Traumatic Brain Injury on Hippocampal Plasticity and Cognitive Function by Reducing Brain-Derived Neurotrophic Factor», Neuroscience 119, no. 2 (2003): 368–75.

Christakis, D. A., et al. «Early Television Exposure and Subsequent Attentional Problems in Children», Pediatrics 113 (April 2004): 708–13.

Diamond, М., S. Cusack, and W. Thompson, «Mental Fitness for Life: A 7 Step Guide to Healthy Aging» (Toronto: Key Porter Books, 2003).

Hancox, R. J., В. I. Milne, and R. Poulton, «Association Between Child and Adolescent Television Viewing and Adult Health: A Longitudinal Birth Cohort Study», Lancet 364, no. 9430 (July 17, 2004): 257–62.

Koepp, M.J., et al. «Evidence for Striatal Dopamine Release During a Video Game», Nature 393, no. 6682 (May 21, 1998): 266–68.

Mohammed, A. H., et al. «Environmental Enrichment and the Brain», Progress in Brain Research 138 (2002): 109–33.

Snowdon, D. A., «Aging and Alzheimer’s Disease: Lessons from the Nun Study», Gerontologist 37, no. 2 (1997): 150–56.

Van Praag, H., G. Kempermann, and F. H. Gage, «Neural Consequences of Environmental Enrichment», Native Reviews-Neuroscience 1, no. 3 (December: 191–98).

Beatty, J. A., et al. «Physical Exercise Decreases Neuronal Activity in the Posterior Hypothalamic Area of Spontaneously Hypertensive Rats», Journal of Applied Physiology 11, no. 2 (October 8, 2004): 75–84.

Colcombe, S. J., et al. «Neurocognitive Aging and Cardiovascular Fitness: Recent Findings and Future Directions», Journal of Molecular Neuroscience 24, no. 1: 9–14.

Friedland, R. P., et al. «Patients with Alzheimer’s Disease Have Reduced Activities in Midlife Compared with Healthy Control-Group Members», Proceedings of the National Academy of Sciences 98, no. 6 (March 13, 2001): 3440–45.

Guszkowska, М., «The Effects of Exercise on Anxiety, Depression and Mood States», Psychiatria Polska 38, no. 4 (July-August 2004): 611–20.

Korf, E. S., et al. «Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study», Hypertension 44, no. 1 (July 2004): 29–34.

Lindsay, J., et al. «Risk Factors for Alzheimer’s Disease: A Prospective Analysis from the Canadian Study of Health and Aging», American Journal of Epidemiology 156, no. 5 (September 1, 2002): 445–53.

Lytle, M. E., et al. «Exercise Level and Cognitive Decline: The Mo VIES Project», Alzheimer Disease and Associated Disorders 18, no. 2 (April-June 2004): 57–64.

Mattson, М. P., «Neuroprotective Signaling and the Aging Brain: Take Away My Food and Let Me Run», Brain Research 886, no. 1–2 (December 15, 2000): 47–53.

Mattson, M. P., S. Maudsley, and B. Martin, «BDNF and 5-HT: A Dynamic Duo in Age-Related Neuronal Plasticity and Neurodegenerative Disorders», Trends in Neuroscience 27, no. 10 (October 2004): 589–94.

Molteni, R., «Exercise Reverses the Harmful Effects of Consumption of a High-Fat Diet on Synaptic and Behavioral Plasticity Associated to the Action of Brain-Derived Neurotrophic Factor», Neuroscience 123, no. 2 (2004): 429–40.

Vaynman, S., Z. Ying, and F. Gomez-Pinilla, «Interplay Between Brain-Derived Neurotrophic Factor and Signal Transduction Modulators in the Regulation of the Effects of Exercise on Synaptic-Plasticity», Neuroscience 122, no. 3 (2003): 647–57.

Draganski, B., et al. «Neuroplasticity: Changes in Grey Matter Induced by Training», Nature 427, no. 6972 (January 22, 2004): 311–12.

Kolb, B., and I. Q. Whishaw, «Brain Plasticity and Behavior», Annual Review of Psychology 49 (1998): 43–64.

Morris, G. S., J. M. Sifft, and G. K. Khalsa, «Effect of Educational Kinesiology on Static Balance of Learning Disabled Students», Perceptual and Motor Skills 67, no. 1 (August 1998): 51–54.

Schlaug, G., «The Brain of Musicians. A Model for Functional and Structural Adaptation», Annals of the New York Academy of Sciences 930 (June 2001): 281–99.

Shaffer, R. J., «Effect of Interactive Metronome Training on Children with ADHD», American Journal of Occupational Therapy 55, no. 2 (March-April 2001): 155–62.

Sifft, J. M., and G. C. Khalsa, «Effect of Educational Kinesiology upon Simple Response Times and Choice Response Times», Perceptual and Motor Skills 73, no. 3, pt. 1 (December 1991): 1011–15.

Ungerleider, I. G., J. Doyon, and A. Karni, «Imaging Brain Plasticity During Motor Skill Learning», Neurobiology of Learning and Memory 78, no. 3 (November 2002): 553–64.

Abramov, L. A., «Sexual Life and Sexual Frigidity Among Women Developing Acute Myocardial Infarction», Psychosomatic Medicine; 8, no. 6 (1976): 418–25.

Burleson, М. H., et al. «Heterosexual Activity and Cycle Length Variability: Effect of Gynecological Maturity», Physiology and Behavior 50 (1991): 863–66.

Catania, J. A., and C. B. White, «Sexuality in an Aged Sample: Cognitive Determinants of Masturbation», Archives of Sexual Behavior 11, no. 3 (1982): 237–45.

Charnetski, C. J., and F. X. Brennan, «Feeling Good Is Good for You: How Pleasure Can Boost Your Immune System and Lengthen Your Life» (Emmaus, Penn.: Rodale Press, 2001).

Coleman, E., «Masturbation as a Means of Achieving Sexual Health», Journal of Psychology and Human Sexuality 14, no. 2–3 (2002): 5–16.

Cutler, W. В., «Love Cycles: The Science of Intimacy» (New York: Villard Books, 1991).

Davey, S., et al. «Sex and Death: Are They Related? Findings from the Caerphilly Cohort Study», British Medical Journal 315 (1997): 1641–44.

Davies, S., et al. «Sexual Desire Discrepancies: Effects on Sexual and Relationship Satisfaction in Heterosexual Dating Couples», Archives of Sexual Behavior 28, no. 6 (1999): 553–67.

Ebrahim, S., et al. «Sexual Intercourse and Risk of Ischaemic Stroke and Coronary Heart Disease: The Caerphilly Study», Journal of Epidemiology Community Health 56 (2002): 99–102.

Ellison, C. R., «Women’s Sexualities» (Oakland, Calif.: New Harbinger, 2000).

Evans, R. W., and J. R. Couch, «Orgasm and Migraine», Headache 41 (2001): 512–14.

Feldman, H. A., et al. «Low Dehydroepiandrosterone Sulfate and Heart Disease in Middle-Aged Men: Cross-Sectional Results from the Massachusetts Male-Aging Study», Annals of Epidemiology 8, no. 4 (1998): 217–28.

Fisher, H. E., «The Sex Contract: The Evolution of Human Behavior» (New York: Quill, 1982).

Fisher, H. E., et al. «Defining the Brain Systems of Lust, Romantic Attraction, and Attachment», Archives of Sexual Behavior 31, no. 5 (2002): 413–19.

Hurlbert, D. F., and К. E. Whittaker, «The Role of Masturbation in Marital and Sexual Satisfaction: A Comparative Study of Female Masturbators and Nonmasturbators», Journal of Sex Education and Therapy 17, no. 4 (1991): 272–82.

Janszky, J., et al. «Orgasmic Aura-A Report of Seven Cases», Seizure 13, no. 6 (September 2004): 441–44.

Janszky, J., et al. «Orgasmic Aura Originates from the Right Hemisphere», Neurology 58, no. 2 (January 22, 2002): 302–04.

Kaplan, H. S., «Desire-Why and How It Changes», Redbook 58 (October 1984); cited in Komisaruk and Whipple, «Suppression of Pain».

Keesling, B., «Rx Sex: Making Love Is the Best Medicine» (Alameda, Calif.: Hunter House, 2000).

Komisaruk, B. R., and B. Whipple, «The Suppression of Pain by Genital Stimulation in Females», Annual Review of Sex Research (1995): 151–86.

Le, M. G., et al. «Characteristics of Reproductive Life and Risk of Breast Cancer in a Case-Control Study of Young Nulliparous Women», Journal of Clinical Epidemiology 42, no. 12 (1989): 1227–33.

Leitzmann, M. F., et al. «Ejaculation Frequency and Subsequent Risk of Prostate Cancer», Journal of the American Medical Association 291, no. 13 (April 7, 2004): 1578–86.

Levin, R., «The Physiology of Sexual Arousal in the Human Female: A Recreational and Progreational Synthesis», Archives of Sexual Behavior 31, no. 5 (2002): 405–11.

Manning, J., and R. Taylor, «Long Ring Fingers and Testosterone», Evolution and Human Behavior 22 (January 2001): 61–69.

Martin, S. М., J. T. Manning, and C. F. Dowrick, «Fluctuating Asymmetry, Relative Digit Length and Depression in Men», Evolution and Human Behavior 20 (1999): 203–14.

Meaddough, E. L., et al. «Sexual Activity, Orgasm and Tampon Use Are Associated with a Decreased Risk for Endometriosis», Gynecologic and Obstetric Investigation 53 (2002): 163–69.

Murrell, T. G. C., «The Potential for Oxytocin (ОТ) to Prevent Breast Cancer: A Hypothesis», Breast Cancer Research and Treatment 35 (1995): 225–29.

Odent, M., «Vie Scientification of Love» (London: Free Association Books, 1999).

Ogden, G., «Spiritual Passion and Compassion in Late-Life Sexual Relationships», Electronic Journal of Human Sexuality (August 14, 2001), http://www.ejhs. org/volume4/ Ogden.htm.

Palmore, E., «Predictors of the Longevity Difference: A Twenty-Five Year Follow-Up», Gerontologist 22 (1982): 513–18.

Persson, G., «Five-Year Mortality in a 70-Year-Old Urban Population in Relation to Psychiatric Diagnosis, Personality, Sexuality and Early Parental Death», Acta Psychiatrica Scandinavica 64 (1981): 244–53.

Petridou, E., et al. «Endocrine Correlates of Male Breast Cancer Risk: A Case-Control Study in Athens, Greece», British Journal of Cancer 83, no. 9 (2000): 1234–37.

Sandel, М. E., et al. «Sexual Functioning Following Traumatic Brain Injury», Brain Injury 10, no. 10 (October 1996): 719–28.

Sayle, A. E., et al. «Sexual Activity During Late Pregnancy and Risk of Preterm Delivery», Obstetrics and Gynecology 97, no. 2 (2001): 283–89.

Shapiro, D., «Effect of Chronic Low Back Pain on Sexuality», Medical Aspects of Human Sexuality 17 (1983): 241–45; cited in Komisaruk and Whipple, «Suppresses of Pain».

Singh, D., et al. «Frequency and Timing of Coital Orgasm in Women Desirous of Becoming Pregnant», Archives of Sexual Behavior 27, no. 1 (1998): 15–29.

Spencer, N. A., et al. «Social Chemosignals from Breastfeeding Women Increase Sexual Motivation», Hormones and Behavior 46, no. 3 (September 2004): 362–70.

Sprecher, S., «Sexual Satisfaction in Premarital Relationships: Associations with Satisfaction, Love, Commitment, and Stability», Journal of Sex Research 39, no. 3 (2002): 190–96.

Tur-Kaspa, I., et al. «How Often Should Infertile Men Have Intercourse to Achieve Conception?» Fertility and Sterility 62, no. 2 (1994): 370–75.

Von Sydow, K., «Sexuality During Pregnancy and After Childbirth: A Metacontent Analysis of 59 Studies», Journal of Psychosomatic Research 47, no. 1 (1999): 27–49.

Walters, A. S., and G. M. Williamson, «Sexual Satisfaction Predicts Quality of Life: A Study of Adult Amputees», Sexuality and Disability 16, no. 2 (1998): 103–15.

Warner, P., and J. Bancroft, «Mood, Sexuality, Oral Contraceptives and the Menstrual Cycle», Journal of Psychosomatic Research 32, nos. 4–5 (1988): 417–27.

Weeks, D., and J. James, «Secrets of the Superyoung» (New York: Berkley Books, 1998).

Whipple, B., and B. R. Komisaruk, «Elevation of Pain Threshold by Vaginal Stimulation in Women», Pain 21 (1985): 357–67.

Wilson, М., and M. Daly, «Do Pretty Women Inspire Men to Discount the Future?» Proceedings of the Royal Society of London, Series B-Biological Sciences 271, Suppl. 4 (May 7, 2004): SI77–79.

Zamboni, В. D., and I. Crawford, «Using Masturbation in Sex Therapy: Relationships Between Masturbation, Sexual Desire, and Sexual Fantasy», Journal of Psychology and Human Sexuality 14, nos. 2–3 (2002): 123–41.

Baxter, L. R., Jr, et al. «Caudate Glucose Metabolic Rate Changes with Both Drug and Behavior Therapy for Obsessive-Compulsive Disorder», Archives of General Psychiatry 49, no. 9 (September 1992): 681–89.

Brody, A. L., et al. «FDG-PET Predictors of Response to Behavioral Therapy and Pharmacotherapy in Obsessive Compulsive Disorder», Psychiatry Research 84, no. 1 (November 9, 1998): 1–6.

Brody, A. L., et al. «Regional Brain Metabolic Changes in Patients with Major Depression Treated with Either Paroxetine or Interpersonal Therapy: Preliminary Findings», Archives of General Psychiatry 58, no. 7 (July 2001): 631–40.

Davidson, J. R., et al. «Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placebo in Generalized Social Phobia», Archives of General Psychiatry 61, no. 10 (October 2004): 1005–13.

Findley, Т., «The Placebo and the Physician», Medical Clinics of North America 1 (November 1983): 1821–26.

Frank, J. D., «The Dynamics of the Psychotherapeutic Relationship: Determinants and Effects of the Therapists Influence», Psychiatry 22, no. 1 (February 1959): 17–39.

Furmark, T., et al. «Common Changes in Cerebral Blood Flow in Patients with Social Phobia Treated with Citalopram or Cognitive-Behavioral Therapy», Archives of General Psychiatry 59, no. 5 (May 2002): 425–33.

Goldapple, K., et al. «Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy», Archives of General Psychiatry 61, no. 1 (January 2004): 34–41.

Levin, P., S. Lazrove, and B. van der Kolk, «What Psychological Testing and Neuroimaging Tell Us About the Treatment of Posttraumatic Stress Disorder by Eye Movement Desensitization and Reprocessing», Journal of Anxiety Disorders 13, nos. 1–2 (January-April 1999): 159–72.

Martin, S. D., et al. «Brain Blood Flow Changes in Depressed Patients Treated with Interpersonal Psychotherapy or Venlafaxine Hydrochloride: Preliminary Findings», Archives of General Psychiatry 58, no. 7 (July 2001): 641–48.

Nakatani, E., et al. «Effects of Behavior Therapy on Regional Cerebral Blood Flow in Obsessive-Compulsive Disorder», Psychiatry Research 124, no. 2 (October 30, 2003): 113–20.

Paquette, V., et al. «Change the Mind and You Change the Brain: Effects of Cognitive-Behavioral Therapy on the Neural Correlates of Spider Phobia», Neuroimage 18, no. 2 (February 2003): 401–09.

Prasko, J., et al. «The Change of Regional Brain Metabolism (18FDG PET) in Panic Disorder During the Treatment with Cognitive Behavioral Therapy or Antidepressants» Neuroendocrinology Letters 25, no. 5 (October 2004): 340–48.

Schwartz, J. М., et al. «Systematic Changes in Cerebral Glucose Metabolic Rate After Successful Behavior Modification Treatment of Obsessive-Compulsive Disorder», Archives of General Psychiatry 53, no. 2 (February 1996): 109–13.

Bridgett, D. J., and J. Cuevas «Effects of Listening to Mozart and Bach on the Performance of a Mathematical Test», Perceptual and Motor Skills 90 (2000): 1171–75.

Campbell, D. «The Mozart Effect: Tapping the Power of Music to Heal the Body, Strengthen the Mind, and Unlock the Creative Spirit» (New York: Avon, 1997).

Carlson, S., et al. «Effects of Music and White Noise on Working Memory Performance in Monkeys», Neuroreport 8 (1997): 2853–56.

Creutzfeldt, O., and G. Ojemann, «Neuronal Activity in the Human Lateral Temporal Lobe. III. Activity Changes During Music», Experimental Brain Research 77 (1989): 490–98.

Esch, T., et al. «Commonalities in the Central Nervous Systems Involvement with Complementary Medical Therapies: Limbic Morphinergic Processes», Medical Science Monitor 10, no. 6 (June 2004): MS6–17.

Formisano, R., et al. «Active Music Therapy in the Rehabilitation of Severe Brain Injured Patients During Coma Recovery», Annali dell'Istituto superiore di sanit’ 37, no. 4 (2001): 627–30.

Gruhn, W., N. Galley, and C. Kluth, «Do Mental Speed and Musical Abilities Interact?» Annals of the New York Academy of Sciences 999 (November 2003): 485–96.

Jausovec, N., and K. Habe, «The ‘Mozart Effect’: An Electroencephalographic Analysis Employing the Methods of Induced Event-Related Desynchronization/Synchronization and Event-Related Coherence», Brain Topography 16, no. 2 (Winter 2003): 73–84.

Johnson, J. K., et al. «Enhancement of Spatial-Temporal Reasoning After a Mozart Listening Condition in Alzheimer’s Disease: A Case Study», unpublished.

Kim, W. S., et al. «Asymmetric Activation in the Prefrontal Cortex by Sound-Induced Affect», Perceptual and Motor Skills 97, no. 3, pt. 1 (December 2003): 847–54.

Koch, J. E., and F. R. Rauscher, «Development of Central Auditory and Spatial Processing Sites: The Effects of Exposure to Music», paper presented at the twenty-seventh annual meeting of the Society for Neuroscience, New Orleans, October 1997.

Miller, A., and D. Coen «The Case for Music in the Schools», Phi Delta Kappan lb, no. 6: 459–61.

Pratt, R. R., «Art, Dance, and Music Therapy», Physical Medicine and Rehabilitation Clinics of North America 15, no. 4 (November 2004): 827–41, vi-viii.

Pratt, R. R., and D. E. Grocke, eds., MusicMedicine, vol. 3, MusicMedicine and Music Therapy: Expanding Horizons (MMB Music, 2001).

Rauscher, F. Н., G. L. Shaw, and К. N. Ку, «Music and Spatial Task Performance», Nature 365 (1993): 611.

«Listening to Mozart Enhances Spatial-Temporal Reasoning: Towards a Neurophysiological Basis», Neuroscience Letters 185 (1995): 44–47.

Rauscher, F. H., et al. «Music Training Causes Long-Term Enhancement of Preschool Children's Spatial-Temporal Reasoning», Neurological Research (1997) 2–8.

Rideout, В. E., and J. Taylor, «Enhanced Spatial Performance Following Ten Minutes Exposure to Music: A Replication», Perceptual and Motor Skills 85, no. 1 (August 1997): 112–14.

Shenoy, К. V., et al. «Learning by Selection in the Trion Model of Cortical Organization», Cerebral Cortex 3, no. 239 (1993):.

Sutoo, D., and K. Akiyama, «Music Improves Dopaminergic Neurotransmission: Demonstration Based on the Effect of Music on Blood Pressure Regulation», Brain Research 1016, no. 2 (August 6, 2004): 255–62.

Berk, L. S., et al. «Modulation of Neuroimmune Parameters During the Eustress of Humor-Associated Mirthful Laughter», Alternative Therapies in Health and Medicine 7, no. 2 (March 2001): 62–72, 74–76.

Berk, L. S., et al. «Neuroendocrine and Stress Hormone Changes During Mirthful Laughter», American Journal of Medical Science 298, no.6 (1989): 390–96.

Cousins, N., «Anatomy of an Illness As Perceived by the Patient» (New York: Bantam, 1991).

Dossey, L., «Healing Words» (San Francisco: HarperSanFrancisco, 1997).

Matthews, D. A., «Faith Factor» (New York: Penguin, 1999).

Murialdo, G., et al. «Relationships Between Cortisol, Dehydroepiandrosterone Sulphate and Insulin-like Growth Factor-I System in Dementia», Journal of Endocrinological Investigation 24 (2001): 139–46.

Newberg, A., «Why Won't God Go Away» (New York: Ballantine Books, 2003).

Sapolsky, R. М., «Why Zebras Don’t Get Ulcers», 3rd ed. (New York: Owl Books, 2004).

«Taming Stress», Scientific American 289, no. 3 (September 2003): 86–95.

«Depression, Antidepressants, and the Shrinking Hippocampus», Proceedings of the National Academy of Science 98, no. 22 (October 23, 2001): 12 320-22.

Bernhardt, Т., К. Maurer, and L. Frolich, «Effect of Daily Living-Related Cognitive Training on Attention and Memory Performance of Persons with Dementia», Zeitschriftfur Gerontologic und Geriatric 35 (2002): 32–38.

Bird, T. D., «Clinical Genetics of Familial Alzheimer’s Disease», in R.D. Terry, et al. eds., Alzheimer Disease (Philadelphia: Lippincott Williams and Wilkins, 1999), 57–67.

Braak, E., et al. «Neuropathology of Alzheimer’s Disease: What Is New Since A. Alzheimer?» European Archives of Psychiatry and Clinical Neuroscience 249 Suppl.3 (1999): 14–22.

Broe, G. A., et al. «Health Habits and Risk of Cognitive Impairment and Dementia in Old Age: A Prospective Study on the Effects of Exercise, Smoking and Alcohol Consumption», Australian and New Zealand Journal of Public Health 22 (1998): 621–23.

Conquer, J. A., et al. «Fatty Acid Analysis of Blood Plasma of Patients with Alzheimer’s Disease, Other Types of Dementia, and Cognitive Impairment», Lipids 35 (2000): 1305–12.

Corbo, R. M., and R. Scacchi, «Apolipoprotein E (APOE) Allele Distribution in the World. Is APOE*4 a ‘Thrifty’ Allele?» Annals of Human Genetics 63 (1999): 301–10.

Cotman, C. W., and N. C. Berchtold, «Exercise: A Behavioral Intervention to Enhance Brain Health and Plasticity», Trends in Neuroscience 25 (2002): 295–301.

Di Castelnuovo, A., et al. «Meta-Analysis of Wine and Beer Consumption in Relation to Vascular Risk», Circulation 105 (2002): 2836–44.

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287 (2002): 3261–63.

Eriksson, P. S., et al. «Neurogenesis in the Adult Human Hippocampus», Nature MedicineA (1998): 1313–17.

Farrag, A. К., et al. «Effect of Surgical Menopause on Cognitive Functions», Dementia and Geriatric Cognitive Disorders 13 (2002): 193–98.

Ficker, J. H., et al. «Changes in Regional CNS Perfusion in Obstructive Sleep Apnea Syndrome: Initial SPECT Studies with Injected Nocturnal 99mTc-HMPAO», Pneumologie 51 (1997): 926–30.

Kabuto, M., et al. «A Prospective Study of Estradiol and Breast Cancer in Japanese Women», Cancer Epidemiology Biomarkers and Prevention 9 (2000): 575–79.

Kalmijn, S., et al. «Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men. The Honolulu-Asia Aging Study», Arteriosclerosis, Thrombosis, and Vascular Biology 20 (2000): 2255–60.

Kawas, C., and R. Katzman, «Epidemiology of Dementia and Alzheimer’s Disease», in R. D. Terry, et al. eds., Alzheimer Disease (Philadelphia: Lippincott Williams and Wilkins, 1999), 95–117.

Kawas, C., et al. «A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer’s Disease: The Baltimore Longitudinal Study of Aging», Neurology 48 (1997): 1517–21.

Kosunen, O., et al. «Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer Patients», Stroke 26 (1995): 743–48.

Launer, L. J., et al. «The Association Between Midlife Blood Pressure Levels and Late-Life Cognitive Function. The Honolulu-Asia Aging Study», Journal of the American Medical Association 274 (1995): 1846–51.

Luchsinger, J. A., et al. «Caloric Intake and the Risk of Alzheimer Disease», Archives of Neurology 59 (2002): 1258–63.

McCleary, R., R. A. Mulnard, and W. R. Shankle, «Reproductive Health Risks in Dementia: Evidence from the 1986 National Mortality Followback Survey», Alzheimer’s Research 2 (1996): 181–84.

Nelson, Н. D., et al. «Postmenopausal Hormone Replacement Therapy: Scientific Review», Journal of the American Medical Association 288 (2002): 872–81.

Riley, K. P., et al. «Cognitive Function and Apolipoprotein E in Very Old Adults: Findings from the Nun Study», Journal of Gerontology, Series В-Psychological Sciences and Social Sciences 55, no. 2 (March 2000): S69–75.

Ruitenberg, A., et al. «Alcohol Consumption and Risk of Dementia: The Rotterdam Study», Lancet 359 (2002): 281–86.

Selkoe, D. J., «AD: Genotypes, Phenotype and Treatment», Science 275 (1997): 630–31.

Seshadri, S., et al. «Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer’s Disease», New England Journal of Medicine 346 (2002): 476–83.

Shankle, W. R., and D. G. Amen, «Preventing Alzheimer’s: Ways to Prevent, Delay or Halt Alzheimer’s and Other Forms of Memory Loss» (New York: Putnam, 2004).

Shankle, W. R., M. S. Rafii, and В. H. Landing, «Functional Relationships Associated with Pattern of Development in Developing Human Cerebral Cortex», Concepts in Neuroscience 4, no. 1 (1993): 77–87.

Shankle, W. R., et al. «Numbers of Neurons Per Column in the Developing Human Cerebral Cortex from Birth to 72 Months: Evidence for an Apparent Post-Natal Increase in Neuron Numbers», Journal of Theoretical Biology 191 (1998): 115–40.

Tang, М. X., et al. «Effect of Age, Ethnicity, and Head Injury on the Association Between APOE Genotypes and Alzheimer’s Disease», Annals of the New York Academy of Sciences 802 (1996): 6–15.

Truelson, T., et al. «Amount and Type of Alcohol and Risk of Dementia: The Copenhagen City Heart Study», Neurology 59 (2002): 1313–19.

Valcour, V. G., et al. «The Detection of Dementia in the Primary Care Setting», Archives of Internal Medicine 160 (2000): 2964–68.

Van Kooten, F., et al. «The Dutch Vascular Factors in Dementia Study: Rationale and Design», Journal of Neurology 245 (1998): 32–39.

Van Dam, F. S., et al. «Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy», Journal of the National Cancer Institute 90 (1998): 210–18.

Wilson, R. S., et al. «Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease», Journal of the American Medical Association 287 (2002): 742–48.

Wilson, R. S., et al. «The Apolipoprotein E Varepsilon 2 Allele and Decline in Episodic Memory», Journal of Neurology, Neurosurgery, Und Psychiatry 73 (2002): 672–77.

Yaffe, K., et al. «Estrogen Receptor 1 Polymorphisms and Risk of Cognitive Impairment in Older Women», Biological Psychiatry 51 (2002): 677–82.

Brooks, J. О., Ill, et al. «Acetyl-L–Carnitine Slows Decline in Younger Patients with Alzheimer’s Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Trial Using the Trilinear Approach», International Psychogeriatrics 10 (1998): 193–203.

Cipolli, C., and G. Chiari, «Effects of L-Acetyl Carnitine on Mental Deterioration in the Aged: Initial Results», Clinical Therapeutics 132 (1990): 479–510.

Garzya, G., et al. «Evaluation of the Effects of L-Acetyl Carnitine on Senile Patients Suffering from Depression», Drugs Under Experimental and Clinical Research 16 (1990): 101–06.

Gorini, A., A. D'Angelo, and R. F. Villa, «Action of L-Acetyl сarnitine on Different Cerebral Mitochondrial Populations from Cerebral Cortex», Neurochemical Research 23 (1998): 1485–91.

Guarnaschelli, C., G. Fugassa, and C. Pistarini, «Pathological Brain Ageing: Evaluation of the Efficacy of a Pharmacological Aid», Drugs Under Experimental and Clinical Research 14 (1998): 715–18.

Lolic, М. М., G. Fiskum, and R. E. Rosenthal, «Neuroprotective Effects of Acetyl-L–Carnitine After Stroke in Rats», Annals of Emergency Medicine 29 (1997): 758–65.

Patti, F., P. Marano, and S. Cappello, «Effects of L-Acetyl Carnitine on Functional Recovery of Hemiplegic Patients», Clinical Trials Journal 25 (1988): 87–101.

Pettegrew, J. W., W. E. Klunke, and K. Panchalingam, «Clinical and Biochemical Effects of Acetyl-L–Carnitine in Alzheimer’s Disease», Neurobiology of Aging 16 (1998): 1–4.

Rai, G., et al. «Double-Blind, Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Dementia», Current Medical Research and Opinion 11 (1990): 638–47.

Salvioli, G., and M. Neri, «L-Acetyl carnitine Treatment of Mental Decline in the Elderly», Drugs Under Experimental and Clinical Research 20 (1994): 169–76.

Sano, M., et al. «Double-Blind Parallel Pilot Study of Acetyl Levocarnitine in Patients with Alzheimer’s Disease», Archives of Neurology 49 (1992): 1137–41.

Spagnoli, A., et al. «Long-Term Acetyl-L–Carnitine Treatment in Alzheimer’s Disease», Neurology 41 (1991): 1726–32.

Tempesta, E., et al. «Role of Acetyl-L–Carnitine in the Treatment of Cognitive Deficit in Chronic Alcoholism», International Journal of Clinical Pharmacological Research 10 (1990): 101–07.

Tempesta, E., et al. «L-Acetylcarnitine in Depressed Elderly Subjects. A Cross-over Study vs. Placebo», Drugs Under Experimental and Clinical Research 10 (1990): 101–07.

Thai, L. J., et al. «A One Year Multicenter Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Disease», Neurology 47 (1996): 705–11.

Marangon, K., et al. «Comparison of the Effect of Alpha-Lipoic Acid and Alpha-Tocopherol Supplementation on Measures of Oxidative Stress», Free Radical Biology and Medicine 27(1999): 1114–21.

Packer, L., H.J. Tritschler, and K. Wessel, «Neuroprotection by the Metabolic Antioxidant Alpha-Lipoic Acid», Free Radical Biology and Medicine 22 (1997): 359–78.

Packer, L., E. H. Witt, and H. J. Tritschler, «Alpha-Lipoic as a Biological Antioxidant», Free Radical Biology and Medicine 79 (1995): 227–50.

Poon, Н. F., et al. «Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with Alpha-Lipoic Acid: Implications for Aging and Age-Related Neuro-degenerative Disorders», Neurochemistry International 46, no. 2 (January 2005): 159–68.

Tirosh, O., et al. «Neuroprotective Effects of Alpha-Lipoic Acid and Its Positively Charged Amide Analogue», Free Radical Biology and Medicine 26 (1999): 1418–26.

Ziegler, D., et al. «Treatment of Symptomatic Diabetic Peripheral Neuropathy with the Antioxidant Alpha-Lipoic Acid. A Three-Week Multicentre Randomized Controlled Trial (ALADIN Study)», Diabetologia 38 (1995): 1425–33.

Baggio, E., et al. «Italian Multicenter Study on the Safety and Efficacy of Coenzyme Q₁₀ as Adjunctive Therapy in Heart Failure», Molecular Aspects of Medicine 15 (Suppl.) (1994): 287–94.

Chopra, R. K., et al. «Relative Bioavailability of Coenzyme Q₁₀ Formulations in Human Subjects», International Journal for Vitamin and Nutrition Research 68 (1998): 109–13.

Crane, F. L, I. L. Sun, and E. E. Sun, «The Essential Functions of Coenzyme Q», Clinical Investigator 71 (Suppl.) (1993): S55–59.

Folkers, K., et al. «Lovastatin Decreases Coenzyme Q Levels in Humans», Proceedings of the National Academy of Science 87 (1990): 8931–34.

Hanaki, Y., et al. «Coenzyme Q₁₀ and Coronary Artery Disease», Clinical Investigator7. (Suppl.) (1993): SI 12–15.

Matthews, R. Т., et al. «Coenzyme Q₁₀ Administration Increases Mitochondrial Concentrations and Exerts Neuroprotective Effects», Proceedings of the National Academy of Science 95(1998): 8892–97.

Shults, C. W, et al. «Pilot Trial of High Dosages of Coenzyme Q₁₀ in Patients with Parkinson’s Disease», Experimental Neurology 188, no. 2 (August 2004): 491–94.

Spigset, O., «Reduced Effect of Warfarin Caused by Ubidecarenone», Lancet 344 (1994): 1372–73.

Adler, A. J., and B. J. Holub, «Effect of Garlic and Fish-Oil Supplementation on Serum Lipid and Lipoprotein Concentrations in Hypercholesterolemic Men», American Journal of Clinical Nutrition 65 (1997): 445–50.

Appel, L. J., et al. «Does Supplementation of Diet with ‘Fish Oil’ Reduce Blood Pressure? A Meta-Analysis of Controlled Clinical Trials», Archives of Internal Medicine 153 (1993): 1429–38.

Ariza-Ariza, R., M. Mestanza-Peralta, and М. H. Cardiel, «Omega-3 Fatty Acid in Rheumatoid Arthritis: An Overview», Seminars in Arthritis and Rheumatism 27 (1998): 366–70.

Belluzi, A., et al. «Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn’s Disease», New England Journal of Medicine 334 (1996): 1557–60.

GISSI-Prevenzione Investigators, «Dietary Supplementation with N-3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial», Lancet 354 (1999): 447–55.

Grimsgaard, S., et al. «Highly Purified Eicosapentaenoic Acid and Docosa-hexaenoic Acids in Humans Have Similar Triacylglycerol-Lowering Effects but Divergent Effects on Serum Fatty Acids», American Journal of Clinical Nutrition 66 (1997): 649–59.

Saldeen, P., and T. Saldeen, «Women and Omega-3 Fatty Acids», Obstetrical and Gynecological Survey 59, no. 10 (October 2004): 722–30, 745–46.

Stoll, A. L., et al. «Omega-3 Fatty Acids in Bipolar Disorder», Archives of General Psychiatry 56 (1999): 407–12.

Blume, J., M. Kieser, and U. Holscher, «[Placebo-Controlled Double-Blind Study of the Effectiveness of Ginkgo Biloba Special Extract EGb 761 in Trained Patients with Intermittent Claudication]», Vasa 25, no. 3 (1996): 265–74.

[Ginkgo-Special-Extract EGb 761 in Peripheral Arterial Occlusive Diseases Stage lib According to Fontaine], Fortschritte JerMedizin 116, nos. 35–36 (1997): 36–37.

Blumenthal, M., A. Goldberg, J. Brinckmann, eds; Tyler, V. E., «Herbal Medicine: Expanded Commission E Monographs» (American Botanical Council, 2000).

Blumenthal, M., et al. eds, Klein, S.; R. S. Rister, trans, V. E. Tyler, «The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines» (American Botanical Council, 1998).

Haase, J., P. Halama, and R. Horr, «Effectiveness of Brief Infusions with Ginkgo Biloba Special Extract EGb 761 in Dementia of the Vascular and Alzheimer Type», Zeitschrift fur Gerontologic und Geriatric 29, no. 4 (1996): 302–09.

Hofferberth, B., «The Effect of Ginkgo Biloba Extract on Neurophysiological and Psychometric Measurement Results in Patients with Psychotic Organic Brain Syndrome. A Double-Blind Study Against Placebo», Arzneimittelforschung 39, no. 8 (1989): 918–22.

Kanowski, S., et al. «Proof of the Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type of Multi-Infarct Dementia», Phytomedicine 4 (1997): 3–13.

Kennedy, D. О., A. B. Scholey, and K. A. Wesnes, «The Dose-Dependent Cognitive Effects of Acute Administration of Ginkgo Biloba to Healthy Young Volunteers», Psychopharmacology 151, no. 4 (2000): 416–23.

Le Bars, P. L. et al. «A Placebo-Controlled, Double-Blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia. North American EGb Study Group», Journal of the American Medical Association 278, no. 16 (1997): 1327–32.

Le Bars, P. L., M. Kieser, and K. Z. Itil, «A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo Biloba Extract EGb 761 in Dementia», Dementia and Geriatric Cognitive Disorders 11, no. 4 (2000): 230–37.

Mix, J. A., and W. D. Crews, Jr., «An Examination of the Efficacy of Ginkgo Biloba Extract EGb 761 on the Neuropsychologic Functioning of Cognitively Intact Older Adults», Journal of Alternative and Complementary Medicine 6, no. 3 (1999): 219–29.

Oken, В. S., D. М. Storzbach, and J. A. Kaye, «The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease», Archives of Neurology 55, no. 11 (1997): 1409–15.

Rigney, U., S. Kimber, and I. Hindmarch, «The Effects of Acute Doses of Standardized Ginkgo Biloba Extract on Memory and Psychomotor Performance in Volunteers», Phytotherapy Research 13, no. 5 (1999): 408–15.

Santos, R. F., et al. «Cognitive Performance, SPECT, and Blood Viscosity in Elderly Non-Demented People Using Ginkgo Biloba», Pharmacopsychiatry 36, no. 4 (July 2003): 127–33.

Stough, C., et al. «Neuropsychological Changes After 30-Day Ginkgo Biloba Administration in Healthy Participants», International Journal of Neuropsychopharmacology 4, no. 2 (2001): 131–34.

Wesnes, K. A., et al. «The Memory Enhancing Effects of a Ginkgo Biloba/Panax Ginseng Combination in Healthy Middle-aged Volunteers», Psychopharmacology 152, no. 4 (2000): 353–61.

Yoshikawa, Т., Y. Naito, and M. Kondo, «Ginkgo Biloba Leaf Extract: Review of Biological Actions and Clinical Applications», Antioxidants and Redox Signaling 1, no. 4 (1999): 469–80.

Amaducc, L. and SMID Group, «Phosphatidylserine in the Treatment of Alzheimer’s Disease. Results of a Multicenter Study», Psychopharmacology Bulletin 24 (1988): 130–34.

Crook, T., et al. «Effects of Phosphatidylserine in Alzheimer’s Disease», Psychopharmacology Bulletin 28 (1992): 61–66.

Crook, Т. H., et al. «Effects of Phosphatidylserine in Age-Associated Memory Impairment», Neurology 41 (1991): 644–49.

Pepeu, G., I., Marconcini Pepeu, and L. Amaducc, «A Review of Phosphatidylserine Pharmacological and Clinical Effects. Is Phosphatidylserine a Drug for the Ageing Brain?» Pharmacological Research 33 (1996): 73–80.

Villardita, C., et al. «Multicentre Clinical Trial of Brain Phophatidylserine in Elderly Patients with Intellectual Deterioration», Clinical Trials Journal 24 (1987): 84–93.

Zanott, A., L. Valzelli, and G. Toffano, «Chronic Phosphatidylserine Treatment Improves Spatial Memory and Passive Avoidance in Aged Rats», Psychopharmacology 99 (1989): 316–21.

Juneja, L. R., et al. «L-Theanine-A Unique Amino Acid of Green Tea and Its Relaxation Effect in Humans», Trends in Food Science and Technology 10 (1999): 199–204.

Lu, K., et al. «The Acute Effects of L-Theanine in Comparison with Alprazolam on Anticipatory Anxiety in Humans», Human Psychopharmacology 19, no. 7 (October 2004): 457–65.

Sadzuka, Y., et al. «The Effects of Theanine, as a Novel Biochemical Modulator, on the Antitumor Activity of Adriamycin», Cancer Letters 105 (1996): 203–09.

Bereczki, D., and I. Fekete, «A Systematic Review of Vinpocetine Therapy in Acute Ischaemic Stroke», European Journal of Clinical Pharmacology 55 (1999): 349–52.

Gulyas, B., et al. «Brain Uptake and Plasma Metabolism of [11C] Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey», Journal of Neuroimaging 9 (1997): 217–22.

Sitges, М., and V. Nekrassov, «Vinpocetine Prevents 4-Aminopyridine-Induced Changes in the EEG, the Auditory Brainstem Responses and Hearing», Clinical Neurophysiology 115, no. 12 (December 2004): 2711–17.

Thai, L. J., et al. «The Safety and Lack of Efficacy of Vinpocetine in Alzheimer’s Disease», Journal of the American Geriatrics Society 37 (1989): 515–20.

Fletcher, R. H., and К. M. Fairfield, «Vitamins for Chronic Disease Prevention in Adults: Clinical Applications», Journal of the American Medical Association 287, no. 23 (June 19, 2002): 3127–29.

Aarsand, A. К., and S. M. Carlsen, «Folate Administration Reduces Circulating Homocysteine Levels in NIDDM Patients on Long-term Metformin Treatment», Journal of Internal Medicine 244 (1998): 169–74.

Anon., «How Folate Fights Disease», Nature Structural Biology 6 (1999): 293–94.

Baik, H. W., and R. M. Russell, «Vitamin B₁₂ Deficiency in the Elderly», Annual Review of Nutrition 19 (1999): 357–77.

Berry, R. J., et al. «Prevention of Neural-Tube Defects with Folic Acid in China», New England Journal of Medicine 341 (1999): 1485–90.

Bottiglieri, T., «Folate, Vitamin B₁₂, and Neuropsychiatric Disorders», Nutrition Reviews 54 (1996): 382–90.

Boushey, C. J., et al. «A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes», Journal of the American Medical Association 274 (1995): 1049–57.

Clarke, R., et al. «Folate, Vitamin B₁₂, and Serum Total Homocysteine Levels in Confirmed Alzheimer’s Disease», Archives of Neurology 55 (1998): 1449–55.

Coppen, A., and J. Bailey, «Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomized, Placebo-Controlled Trial», Journal of Affective Disorders 60 (2000): 121–30.

Coppen, A., S. Chaudhry, and C. Swade, «Folic Acid Enhances Lithium Prophylaxis», Journal of Affective Disorders 10 (1986): 9–13.

Czeizel, A. E., and I. Dudas, «Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation», New England Journal of Medicine 327 (1992): 1832–35.

Guilarte, Т. R., «Vitamin B₆ and Cognitive Development: Recent Research Findings from Human and Animal Studies», Nutrition Reviews 51 (1993): 193–98.

Homocysteine Lowering Trialists’ Collaboration, «Lowering Blood Homocysteine with Folic Acid Based Supplements: Meta-Analysis of Randomized Trials», British Medical Journal 316 (1998): 894–98.

Leklem, J. E., «Vitamin B₆», in M.E. Shils et al. eds, «Modern Nutrition in Health and Disease», 9th ed. (Baltimore: Williams and Wilkins, 1999), 413–21.

Lindenbaum, J., et al. «Neuropsvchiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis», New England Journal of Medicine 318 (1988): 1720–28.

McCaddon, A., and C. L. Kelly, «Familial Alzheimer’s Disease and Vitamin B₁₂ Deficiency», Age and Ageing 23 (1994): 334–37.

Rimm, E. B., et al. «Higher Intake of Folate and Vitamin B₆ Is Associated with Low Rates of Coronary Artery Disease in Women», Journal of the American Medical Association 279 (1998): 359–64.

Snowdon, D. A., et al. «Serum Folate and the Severity of Atrophy of the Neocortex in Alzheimer Disease: Findings from the Nun Study», American Journal of Clinical Nutrition 71 (2000): 993–98.

Sumner, A. E., et al. «Elevated Methylmalonic Acid and Total Homocysteine Levels Show High Prevalence of Vitamin B₁₂ Deficiency After Gastric Surgery», Annals of Internal Medicine 124 (1996): 469–76.

Weir, D. G., and J. M. Scott, «Brain Function in the Elderly: Role of Vitamin B₁₂ and Folate», British Medical Bulletin 55 (1999): 669–82.

Wyatt, К. M., et al. «Efficacy of Vitamin B₁₂ in the Treatment of Premenstrual Syndrome: Systemic Review», British Medical Journal (1999): 1375–81.

Age-Related Eye Disease Study Research Group, «A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins С and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8», Archives of Ophthalmology 119, no. 10 (October 2001): 1417–36.

«Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids» (Washington, D.C.: National Academy Press, 2000).

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.

Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy I, no. 1 (September 2003): 3–10.

Lykkesfeldt, J., et al. «Ascorbate Is Depleted by Smoking and Repleted By Moderate Supplementation: A Study in Male Smokers and Nonsmokers with Matched Dietary Intakes», American Journal of Clinical Nutrition 71 (2000): 530–36.

Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.

Adler, L. A., et al. «Vitamin E Treatment for Tardive Dyskinesia», Archives of General Psychiatry 56 (1999): 836–41.

Anderson, D. К., T. R. Waters, and E. D. Means, «Pretreatment with Alpha-Tocopherol Enhances Neurologic Recovery After Experimental Spinal Cord Compression Injury», Journal of Neurotrauma 5, no. 61 (1998): 61–67.

Aslam, A., et al. «Vitamin E Deficiency Induced Neurological Disease in Common Variable Immunodeficiency: Two Cases and a Review of the Literature of Vitamin E Deficiency», Clinical Immunology 112, no. 1 (July 2004): 24–29.

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.

GISSI-Prevenzionc Investigators, «Dietary Supplementation with N-3 Polyunsaturated Fatty Acids and Vitamin E after Myocardial Infarction: Results of the GlSSI-Prevenzioni Trial», Lancet 354 (1999): 447–55.

Gray, S. I., et al. «Predictors of Nutritional Supplement Use by the Elderly», Pharmacotherapy 16, no. 4 (July-August 1996): 715–20.

Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy 1, no. 1 (September 2003): 3–10.

Grundman, M., «Vitamin E and Alzheimer’s Disease: The Basis for Additional Clinical Trials», American Journal of Clinical Nutrition 71 (2000): 630S-36S.

Miller, E. R., Ill, et al. «Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality», Annals of Internal Medicine (January 4, 2005): 37–46.

Rimm, E. B., et al. «Vitamin E Consumption and the Risk of Coronary Heart Disease in Men», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1450–56.

Rutten, B. P., et al. «Antioxidants and Alzheimer’s Disease: From Bench to Bedside (and Back Again)», Current Opinion in Clinical Nutrition and Metabolic Care 5, no. 6 (November 2002): 645–51.

Shoulson, I., «DATATOP: A Decade of Neuroprotective Inquiry. Parkinson Study Group. Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism», Annals of Neurology 44, no. 3 suppl. 1 (1998): S160–66.

Stampfer, M. J., et al. «Vitamin E Consumption and the Risk of Coronary Disease in Women», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1444–49.

Iraber, M. G., «Which Form of Vitamin E, Alpha-or Gamma-Tocopherol, Is Better?» Linus Pauling Institute Report (2002).

Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.

Wu, A., Z. Ying, and F. Gomez-Pinilla, «The Interplay Between Oxidative Stress and Brain-Derived Neurotrophic Factor Modulates the Outcome of a Saturated Fat Diet on Synaptic Plasticity and Cognition», European Journal of Neuroscience 19, no. 7 (April 2004): 1699–707.

Bell, К. М., et al. «S-Adenosylmethionine Treatment of Depression: A Controlled Clinical Trial», American Journal of Psychiatry 145, no. 9 (1988): 1110–14.

Bell, К. М., et al. «S-Adenosylmethionine Blood Levels in Major Depression: Changes with Drug Treatment», Acta Neurologica Scandinavica 154 (Suppl.) (1994): 15–18.

Berlanga, C., et al. «Efficacy of S-Adenosyl-L-Methionine in Speeding the Onset of Action of Imipramine», Psychiatry Research 44, no. 3 (1992): 257–62.

Glorioso, S., et al. «Double-Blind Multicentre Study of the Activity of S-Adenosylmethionine in Hip and Knee Osteoarthritis», International Journal of Clinical Pharmacology Research 5, no. 1 (1985): 39–49.

Jacobsen, S., B. Danneskiold-Samsoe, and R. B. Andersen, «Oral S-Adenosylmethionine in Primary Fibromyalgia. Double-Blind Clinical Evaluation», Scandinavian Journal of Rheumatology 20, no. 4 (1991): 294–302.

Kagan, B. L., et al. «Oral S-Adenosylmethionine in Depression: A Randomized, Double-Blind, Placebo-Controlled Trial», American Journal of Psychiatry 147, no. 5 (1990): 591–95.

Maccagno, A., et al. «Double-Blind Controlled Clinical Trial of Oral S-Adenosylmethionine Versus Piroxicam in Knee Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 72–77.

Mantero, M., et al. «Controlled Double-Blind Study (SAMe-Imipramine) in Depressive Syndromes», Minerva Medica 66, no. 78 (1975): 4098–101.

Muller-Fassbender, H., «Double-Blind Clinical Trial of S-Adenosylmethionine Versus Ibuprofen in the Treatment of Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 81–83.

Salmaggi, P., et al. «Double-Blind, Placebo-Controlled Study of S-Adenosyl-L-Methionine in Depressed Postmenopausal Women», Psychotherapy and Psychosomatics 59, no. 1 (1993): 34–40.

Tavoni, A., et al. «Evaluation of S-Adenosylmethionine in Primary Fibromyalgia. A Double-Blind Crossover Study», American Journal of Medicine 83, no. 5A (1987): 107–10.

Vetter, G., «Double-Blind Comparative Clinical Trial with S-Adenosylmethionine and Indomethacin in the Treatment of Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 78–80.

Volkmann, H., et al. «Double-Blind, Placebo-Controlled Cross-over Study of Intravenous S-Adenosyl-L-Methionine in Patients with Fibromyalgia», Scandinavian Journal of Rheumatology 26, no. 3 (1997): 206–11.

Behnke, K., et al. «Hypericum Perforatum Versus Fluoxetine in the Treatment of Mild to Moderate Depression», Advances in therapy 19, no. 1 (2002): 43–52.

Brenner, R., et al. «Comparison of an Extract of Hypericum (LI 160) and Sertraline in the Treatment of Depression: A Double-blind, Randomized Pilot Study», Clinical Therapeutics 22, no. 4 (2000): 411–19.

Czekalla, J., et al. «The Effect of Hypericum Extract on Cardiac Conduction as Seen in the Electrocardiogram Compared to that of Imipramine», Pharmacopsychiatry 30, suppl. 2 (1990): 86–88.

Friede, М., H. H. Henneicke von Zepelin, and J. Freudenstein, «Differential Therapy of Mild to Moderate Depressive Episodes (ICD-10 F 32.0; F 32.1) with St. John’s Wort», Pharmacopsychiatry 34, Suppl 1 (2001): S38–41.

Hansgen, K., D. J. Vesper, and M. Ploch, «Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S15–18.

Harrer, G., W. D. Hubner, and H. Podzuweit, «Effectiveness and Tolerance of the Hypericum Extract LI 16 °Compared to Maprotiline: A Multicenter Double-Blind Study», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S24–28.

Hubner, W. D, S. Lande, and H. Podzuweit, «Hypericum Treatment of Mild Depressions with Somatic Symptoms», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): SI2–14.

Johnson, D., et al. «Effects of Hypericum Extract LI 16 °Compared with Maprotiline on Resting EEG and Evoked Potentials in 24 Volunteers», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S44–46.

Kalb, R., R. D. Trautmann-Sponsel, and M. Kieser, «Efficacy and Tolerability of Hypericum Extract WS 5572 Versus Placebo in Mildly to Moderately Depressed Patients. A Randomized Double-Blind Multicenter Clinical Trial», Pharmacopsychiatry 34, no. 3 (2001): 96–103.

Laakmann, G., et al. «St. John’s Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy», Pharmacopsychiatry 31, Suppl 1 (1998): 54–59.

Philipp, М., R. Kohnen, and K. O. Hiller, «Hypericum Extract Versus Imipramine or Placebo in Patients with Moderate Depression: Randomised Multicentre Study of Treatment for Eight Weeks», British Medical Journal 319, no. 7224 (1998): 1534–38.

Sommer, H., and G. Harrer, «Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients», Journal of Geriatric Psychiatry and Neurology 7, Suppl 1 (1994): S9–11.

Witte, B., et al. «Treatment of Depressive Symptoms with a High Concentration Hypericum Preparation. A Multicenter Placebo-Controlled Double-Blind Study», Fortschrilt der Medizin 113, no. 28 (1995): 404–08.

Vorbach, E. U., W. D. Hubner, and К. H. Arnoldt, «Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 Outpatients», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S19–23.

Alino, J. J., L. Gutierrez, and М. I.. Iglesias, «5-Hydroxytryptophan (5-HTP) and a MAOI (Nialamide) in the Treatment of Depressions. A Double-Blind Controlled Study», International Pharmacopsychiatry 11, no. 1 (1976): 8–15.

Kahn, R. S., et al. «Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders: A Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and Placebo», International Clinical Psychopharmacology 2, no. 1 (1987): 33–45.

Nardini, M., et al. «Treatment of Depression with L-5-Hydroxytryptophan Combined with Chlorimipramine, A Double-Blind Study», International Journal of Clinical Pharmacology Research 3, no. 4 (1983): 239–50.

Ribeiro, C. A., «L-5-hydroxytryptophan in the Prophylaxis of Chronic Tension-type Headache: A Double-Blind, Randomized, Placebo-Controlled Study. For the Portuguese Head Society», Headache 40, no. 6 (2000): 451–56.

Rousseau, J. J., «Effects of a Levo-5-Hydroxytryptophan-Dihydroergocristine Combination on Depression and Neuropsychic Performance: A Double-Blind Placebo-Controlled Clinical Trial in Elderly Patients», Clinical Therapeutics 9, no. 3(1987): 267–72.

Barak, Y., et al. «Inositol Treatment of Alzheimer’s Disease: A Double-Blind, Cross-over Placebo-Controlled Trial», Progress in Neuropsychopharmacological and Biological Psychiatry 20 (1996): 729–35.

Benjamin, J., et al. «Double-Blind, Placebo-Controlled, Crossover Trial of Inositol Treatment for Panic Disorder», American Journal of Psychiatry 152 (1995): 1084–86.

Einat, H., et al. «Inositol Reduces Depressive-like Behaviors in Two Different Models of Depression», Psychopharmacology 144 (1999): 158–62.

Fox, М., et al. «Inositol Treatment of Obsessive-Compulsive Disorder», American Journal of Psychiatry 153 (1996): 1219–21.

Levine, J., «Controlled Trials of Inositol in Psychiatry», European Neuropsychopharmacology 7 (1997): 147–55.

Levine, J., et al. «Double-Blind, Controlled-Trial of Inositol Treatment of Depression», American Journal of Psychiatry 152 (1995): 792–94.

Levine, J., et al. «CSF Inositol in Schizophrenia and High-Dose Inositol Treatment of Schizophrenic», European Neuropsychopharmacology 4 (1994): 487–90.

Seedat, S., and D.J. Stein, «Inositol Augmentation of Serotonin Reuptake Inhibitors in Treatment-Refractory Obsessive-Compulsive Disorder: An Open Trial», International Clinical Psychopharmacology 14 (1999): 353–56.

Davidson, J. R. Т., and К. M. Connor, «Valerian», in Herbs for the Mind: Depression, Stress, Memory Loss, and Insomnia (New York: Guilford Press, 2000), 214–33.

Donath, F., et al., «Roots I: Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality», Pharmacopsychiatry 33 (2000): 47–53.

Dorn, M., «Valerian Versus Oxazepam: Efficacy and Tolerability in Nonorganic and Nonpsychiatric Insomniacs: A Randomized, Double-Blind, Clinical Comparative Study [in German]», Forschende Komplementarmedizin und Klassische Naturheilkunde 7 (2000): 79–84.

Russo, E. В., «Valerian», in Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies in Psychiatric Conditions (Binghamton, N.Y.: Haworth Press, (2001), 95–706.

Vorbach, E. U., R. Gortelmeyer, and J. Bruning, «Treatment of Insomnia: Effectiveness and Tolerance of a Valerian Extract», Psychopharmakotherapie 3 (1996): 109–15.

Amen, D. G., «Attention Deficit Disorder: A Guide for Primary Care Physicians», Primary Psychiatry 5, no. 7 (July 1998): 76–85.

«Change Your Brain, Change Your Life» (New York: Three Rivers Press, 1999).

«Images of Human Behavior», A Brain SPECT Atlas (Newport Beach, Calif.: Mindworks Press, 2001).

«Healing ADD: The Breakthrough Program That Allows You to See and Heal the Six Types of Attention Deficit Disorder» (New York: G.P. Putnam and Sons, 2001).

Amen, D. G., with L. Routh, «Healing Anxiety and Depression» (New York: Putnam, 2003).

Amen, D. G., «Why Don’t Psychiatrists Look at the Brain: The Case for the Greater Use of SPECT Imaging in Neuropsychiatry», Neuropsychiatry Reviews 2, no. 1 (February 2001): 19–21.

Bonte, F. J., et al. «Brain Blood Flow in the Dementias: SPECT with Histopathologic Correlation in 54 Patients», Radiology 202 (1997): 793–97.

«Brain Perfusion Single Photon Emission Computed Tomography (SPECT) Using Tc-99m Radiopharmaceuticals 2.0. Approved 1999», in Society of Nuclear Medicine Procedure Guidelines Manual (June 2002).

Camargo, E. E., «Brain SPECT in Neurology and Psychiatry», Journal of Nuclear Medicine 42, no. 4 (April 2001): 611–23.

Chiron, C., et al. «Changes in Regional Cerebral Blood Flow During Brain Maturation in Children and Adolescents», Journal of Nuclear Medicine 33, no. 5 (May 1992): 696–703.

George, M. S., «Neuroactivation and Neuroimaging with SPECT» (New York: Springer-Verlag, 1991).

Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology: Assesment of Brain SPECT 46 (1996): 278–85.

Villanueva-Meyer, J., et al. «Cerebral Blood Flow During a Mental Activation Task: Responses in Normal Subjects and in Early Alzheimer Disease Patients», Alasbimn Journal 1, no. 3 (2000): http://www.alasbimnjournal.d/revistas/3/ villanuevaa.htm.